Journal of the National Cancer Institute
Uptake of oncology-related biosimilars: a global analysis of usage data.
Martin K H Ho, Shanzeh Chaudhry, Jennifer Chai, Carlo Deangelis, Kelvin K W Chan, Mina Tadrous
Published: 202510.1093/jnci/djaf335
Abstract
BACKGROUND: Biologics have greatly improved cancer management but are costly. Biosimilars cost less and have no clinically meaningful differences compared to reference products. However, they are not identical, leading to hesitation among clinicians…
Preview only. Read the full abstract at the source